US Stock Market Move | Lumexa Imaging (LMRI.US) listed on the US stock market opened with an increase of over 1.6%

On Thursday, the American outpatient imaging diagnostic services provider Lumexa Imaging (LMRI.US) debuted on the U.S. stock market. The stock opened more than 1.6% higher at $18.8, above its IPO price of $18.5. Lumexa Imaging is headquartered in North Carolina and is a national provider of outpatient diagnostic imaging services. It operates 184 centers in 13 states in the U.S. through wholly-owned operations and joint ventures with medical systems. The company offers a variety of advanced and routine imaging services including MRI, CT scans, PET scans, X-rays, ultrasound, and mammograms. Founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, the company initially had 20 centers and later expanded through 20 acquisitions and the opening of 41 new centers. Currently, Lumexa Imaging has built a diversified referral network with over 29,000 cooperating physicians covering approximately 100,000 individuals. Data shows that the company had sales of $1 billion in the 12 months ending on September 30th, 2025.